0001209191-19-053841.txt : 20191023 0001209191-19-053841.hdr.sgml : 20191023 20191023162149 ACCESSION NUMBER: 0001209191-19-053841 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191021 FILED AS OF DATE: 20191023 DATE AS OF CHANGE: 20191023 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jenne Kyle CENTRAL INDEX KEY: 0001791857 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38137 FILM NUMBER: 191163983 MAIL ADDRESS: STREET 1: C/O AKCEA THERAPEUTICS, INC. STREET 2: 22 BOSTON WHARF ROAD, 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001662524 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472608175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 22 BOSTON WHARF RD STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-207-0202 MAIL ADDRESS: STREET 1: 22 BOSTON WHARF RD STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-10-21 0 0001662524 AKCEA THERAPEUTICS, INC. AKCA 0001791857 Jenne Kyle C/O AKCEA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 9TH FLOOR BOSTON MA 02210 0 1 0 0 Chief Commercial Officer Common Stock 2019-10-21 4 A 0 25000 0.00 A 36711 D Stock Option (right to buy) 18.94 2019-10-21 4 A 0 50000 0.00 A 2029-10-20 Common Stock 50000 50000 D The shares vest as follows: 1/4th of the shares vest one year after October 21, 2019;1/48th of the shares vest monthly thereafter over the next three years. /s/ Joshua F. Patterson, Attorney-in-Fact 2019-10-23